Business: Cloudflare CEO says crypto exchanges are a popular target for cyber attackers

Dr. Deena Hinshaw
CMOH_Alberta

Business: Cloudflare CEO says crypto exchanges are a popular target for cyber attackers

Governor Phil Murphy
GovMurphy

BREAKTHROUGH CASES UPDATE:
➡️5,312,016 fully vaccinated individuals as of August 30th
 
Among the fully vaccinated:
➡️18,390 COVID+ cases (0.35%)
➡️386 COVID-related hospitalizations (0.007%)
➡️97 COVID-related deaths (0.002%) pic.twitter.com/jpZuE6P5kg
20:20 11/07/53671
Twitter

Business: Cloudflare CEO says crypto exchanges are a popular target for cyber attackers

Jonathan Swan
jonathanvswan

New w @HansNichols: The Biden administration is quietly pressuring India to restart vaccine exports with plans to offer a higher-profile role for Modi at an upcoming COVID-19 global summit in New York if he agrees to release vaccines soon. www.axios.com/scoop-the-modi-shot-campaign-de4da455-5ab2-468b-b8ff-c8db3072589a.html?utm_campaign=organic&utm_medium=socialshare&utm_source=twitter
04:13 10/02/53672
Twitter

Business: Cloudflare CEO says crypto exchanges are a popular target for cyber attackers

Tedros Adhanom Ghebreyesus
DrTedros

Good meeting with @DrRHatchett on preparing for future outbreaks & leveraging #COVID19 lessons, incl. prioritizing equity from the start, swift vaccine development & deployment, diversifying manufacturing capacity, ensuring financing is in place. Thank you for your partnership! pic.twitter.com/eLAzOZUM32
07:53 12/04/53671
Twitter

Business: Cloudflare CEO says crypto exchanges are a popular target for cyber attackers

The experts reviewed studies of the vaccines’ performance and concluded the shots are working well despite the extra-contagious delta variant, especially against severe disease.

“Even in populations with fairly high vaccination rates, the unvaccinated are still the major drivers of transmission” at this stage of the pandemic, they concluded.

The opinion piece, published in The Lancet, illustrates the intense scientific debate about who needs booster doses and when, a decision the U.S. and other countries are grappling with.

After revelations of political meddling in the Trump administration’s coronavirus response, President Joe Biden has promised to “follow the science.” But the review raises the question of whether his administration is moving faster than the experts.

The authors include two leading vaccine reviewers at the Food and Drug Administration, Drs. Phil Krause and Marion Gruber, who recently announced they will be stepping down this fall. Among the other 16 authors are leading vaccine researchers in the U.S., Britain, France, South Africa and India, plus scientists with the World Health Organization, which already has urged a moratorium on boosters until poor countries are better vaccinated.

In the U.S., the White House has begun planning for boosters later this month, if both the FDA and Centers for Disease Control and Prevention agree. Advisers to the FDA will weigh evidence about an extra Pfizer shot Friday at a key public meeting.

Georgetown University’s Larry Gostin said the paper “throws gasoline on the fire” in the debate about whether most Americans truly need boosters and whether the White House got ahead of scientists.

“It’s always a fundamental error of process to make a scientific announcement before the public health agencies have acted and that’s exactly what happened here,” said Gostin, a lawyer and public health specialist.

The FDA did not respond to requests for comment Monday morning.

The U.S. already offers an extra dose of the Pfizer or Moderna vaccines to people with severely weakened immune systems.

For the general population, the debate is boiling down to whether boosters should be given even though the vaccines are still offering high protection against severe disease — possibly in hopes of blocking milder “breakthrough” infections among the fully vaccinated.

Last week, CDC Director Dr. Rochelle Walensky said new data showed that as delta surged, the unvaccinated were 4.5 times more likely than the fully vaccinated to get infected, over 10 times more likely to be hospitalized and 11 times more likely to die. Still, government scientists are also weighing hints that protection is waning among older adults who were vaccinated early last winter.

The writers of Monday’s commentary reported reviewing worldwide studies since delta began surging, mostly of U.S. and European vaccines. The team concluded “none of these studies has provided credible evidence of substantially declining protection against severe disease.”

Because the body builds layers of immunity, gradual drops in antibody levels don’t necessarily mean overall effectiveness is dropping “and reductions in vaccine efficacy against mild disease do not necessarily predict reductions in the (typically higher) efficacy against severe disease,” they wrote.

The more the virus spreads, the more opportunity it has to evolve into strains that could escape current vaccines. The Lancet reviewers suggest there could be bigger gains from creating booster doses that better match circulating variants, much like flu vaccine is regularly updated, than from just giving extra doses of the original vaccine.

“There is an opportunity now to study variant-based boosters before there is widespread need for them,” the scientists wrote.

PUT 1xbet
Natasha Kumar

By Natasha Kumar

Natasha Kumar has been a reporter on the news desk since 2018. Before that she wrote about young adolescence and family dynamics for Styles and was the legal affairs correspondent for the Metro desk. Before joining The Times Hub, Natasha Kumar worked as a staff writer at the Village Voice and a freelancer for Newsday, The Wall Street Journal, GQ and Mirabella. To get in touch, contact me through my